STATE OF WISCONSIN INVESTMENT BOARD - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 199 filers reported holding DENALI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,018,769
-30.6%
97,856
-0.7%
0.01%
-25.0%
Q2 2023$2,909,361
+43.8%
98,589
+12.3%
0.01%
+33.3%
Q1 2023$2,023,511
-15.9%
87,826
+1.5%
0.01%
-25.0%
Q4 2022$2,407,400
-10.4%
86,566
-1.1%
0.01%
-11.1%
Q3 2022$2,687,000
+4.8%
87,556
+0.5%
0.01%
+28.6%
Q2 2022$2,565,000
-34.5%
87,139
-28.5%
0.01%
-12.5%
Q1 2022$3,918,000
-27.9%
121,8000.0%0.01%
-20.0%
Q4 2021$5,432,000
-13.2%
121,800
-1.8%
0.01%
-23.1%
Q3 2021$6,256,000
-35.0%
124,000
+1.1%
0.01%
-35.0%
Q2 2021$9,625,000
+87.9%
122,700
+36.8%
0.02%
+81.8%
Q1 2021$5,122,000
-34.5%
89,700
-3.9%
0.01%
-38.9%
Q4 2020$7,815,000
+116.2%
93,300
-7.5%
0.02%
+100.0%
Q3 2020$3,615,000
+80.3%
100,900
+21.7%
0.01%
+50.0%
Q2 2020$2,005,000
+42.1%
82,900
+2.9%
0.01%
+20.0%
Q1 2020$1,411,000
+12.7%
80,600
+12.1%
0.01%
+66.7%
Q4 2019$1,252,000
+13.6%
71,9000.0%0.00%0.0%
Q3 2019$1,102,000
-19.8%
71,900
+8.6%
0.00%
-25.0%
Q2 2019$1,374,000
-4.1%
66,200
+7.3%
0.00%0.0%
Q1 2019$1,433,000
+45.8%
61,700
+29.6%
0.00%
+33.3%
Q4 2018$983,000
-3.8%
47,600
+1.3%
0.00%0.0%
Q3 2018$1,022,00047,0000.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Crestline Management, LP 7,460,732$240,012,00028.78%
Casdin Capital, LLC 1,500,000$48,255,0002.16%
Flagship Pioneering Inc. 2,619,968$84,284,0001.98%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 38,000$8,192,0001.85%
Yiheng Capital Management, L.P. 1,014,684$32,642,0001.49%
SECTORAL ASSET MANAGEMENT INC 207,100$6,662,0001.18%
Artal Group S.A. 600,000$19,302,0000.81%
GILDER GAGNON HOWE & CO LLC 2,619,217$84,260,0000.78%
Temasek Holdings (Private) Ltd 5,369,487$172,736,3970.73%
BRANDYWINE MANAGERS, LLC 9,601$309,0000.53%
View complete list of DENALI THERAPEUTICS INC shareholders